Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.65 by 12.31 percent. This is a 1.35 percent decrease over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $192.400 million which beat the analyst consensus estimate of $190.816 million by 0.83 percent. This is a 6.24 percent increase over sales of $181.099 million the same period last year.